Dapto is proven drug with almost a billion in revenue which = the wall street herd moving in with all guns blazing. CTIX has a potential disruptive technology but it is at least a year if not two away from commercialization. When Brilacidin is licensed, partnered, sold or self developed, then CTIX will move like other public companies.
CTIX is still a zero revenue company, unknown to 99.999% of investors, and Leo hasn't seen a deal come across his desk that he is willing to do.
In venture investing one always bets on the jockey first, then the horse. Leo has made is quite clear that he is looking out for shareholders and has proven to have given consistent updates of company progress (both official and back channel). He is proving to be a great jockey (perfect no, but a solid operator).
Along those lines, I can't believe some are bitching about additional thoughts given to KarinCA by Leo. It helps us know what his motivations and goals are (something that we'd never get via a PR). When I see personal attacks in response to additional information, I'm reminded that we're still in amateur hour. It looks like I'll need to use the ignore feature much more often as a result.
Market Data 
Markets 
AI
